Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Intravenous Immunoglobulin Market from 2024 to 2025?

Recent years have seen significant expansion in the intravenous immunoglobulin market size. The market, which is set to progress from $14.66 billion in 2024 to $15.72 billion in 2025, has a compound annual growth rate (CAGR) of 7.2%. This robust growth in the previous period has been driven by several factors. These include treating primary immune deficiency disorders, managing neurological disorders, a growing older population, advances in plasma fractionation techniques, broadened indications in neurology, and treating infectious diseases along with pediatric immune deficiency.

What Is the Projected Market Size of the Intravenous Immunoglobulin Market?

In the coming years, the intravenous immunoglobulin market is predicted to experience significant expansion, reaching a market size of $22.01 billion by 2029 through an annual growth rate of 8.8%. The forecasted period’s growth could be due to various factors such as a surge in autoimmune disorders, ongoing immunology research, increased spending in healthcare, rising cancer cases, innovative immunoglobulin products, and personalized medicine approaches. The period may also witness primary trends such as the treatment of primary immunodeficiency disorders (PIDD), fast-paced technological innovations, strategic collaborations and partnerships, developments in manufacturing processes, neurology indications, usage in hematology, and progress in immunotherapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

Who are the Major Competitors in the Intravenous Immunoglobulin Market Outlook?

Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

What Is Fueling Growth in the Intravenous Immunoglobulin Market?

The growth of the intravenous immunoglobulin market is projected to be fueled by the rise in the elderly population. Individuals above 65 years old are typically considered part of the geriatric population. As they age, their immune systems become less effective, resulting in an insufficient amount of antibodies. Hence, there is a need for immunoglobulins to supplement these antibodies. This causes a surge in the demand for intravenous immunoglobulins, thus propelling the intravenous immunoglobulin market. For example, the Population Reference Bureau, a nonprofit organization based in Kenya, revealed in January 2024 that the American population aged 65 and older is forecasted to substantially increase from 58 million in 2022 to 82 million by 2050, signifying a 47% increment. Concurrently, it is expected that this demographic will make up 23% of the total population, a rise from the current 17%. Thus, the escalating elderly population will undoubtedly spur the expansion of the intravenous immunoglobulin market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8538&type=smp

Which Intravenous Immunoglobulin Market Segments Are Growing the Fastest?

The intravenous immunoglobulin market covered in this report is segmented –

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

Subsegments:

1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG

2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM

3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA

4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE

5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD

Which Industry Trends Are Shaping the Future of the Intravenous Immunoglobulin Market?

A notable developing trend in the intravenous immunoglobulin market is product innovation. To maintain their market presence and edge, major firms in this sector are emphasizing the concept of product innovation, introducing new items such as liquid immune globulin formulations for treating immunodeficiency diseases. An example of this is Alyglo, an innovative product launched by GC Pharma, a pharmaceutical firm based in South Korea, in December 2023. Authorized by the US Food and Drug Administration, Alyglo is a sterile, ready-to-use liquid containing 10% Immunoglobulin G (IgG), offering 100 mg/mL of protein, out of which a minimum of 96% is human IgG sourced from pooled human plasma. It is designated specifically for individuals aged 17 years and above suffering from primary humoral immunodeficiency (PI). The diseases that fall under this category include congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Which Countries Are Leading the Intravenous Immunoglobulin Market?

North America was the largest region in the intravenous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8538

This Report Delivers Insight On:

1. How big is the intravenous immunoglobulin market, and how is it changing globally?

2. Who are the major companies in the intravenous immunoglobulin market, and how are they performing?

3. What are the key opportunities and risks in the intravenous immunoglobulin market right now?

4. Which products or customer segments are growing the most in the intravenous immunoglobulin market?

5. What factors are helping or slowing down the growth of the intravenous immunoglobulin market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model